SCHEMBL8264202

SCHEMBL8264202

Cc1cccc(-c2cccc(O)c2F)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B14 Q9BPX1 1/20 0.51
RPS6KA3 P51812 1/20 0.47
CNR2 P34972 4/20 0.46
CNR1 P21554 3/20 0.46
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
ACHE P22303 2/20 0.42
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
PDK2 Q15119 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ABCB1 P08183 1/20 0.40
ACLY P53396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29893681 0.86 ACHE (0.50) RPS6KA3CNR2CNR1AKR1C3AKR1C2
SCHEMBL2411804 0.82 CNR2 (0.58) CNR2CNR1CA12CA9ACHE
SCHEMBL29360255 0.82 CNR2 (0.58) CNR2CNR1CA12CA9ACHE
SCHEMBL30522728 0.81 CA12 (0.51) RPS6KA3CNR2CNR1CA12CA9
SCHEMBL1007613 0.81 CA12 (0.51) RPS6KA3CNR2CNR1CA12CA9
SCHEMBL9742510 0.81 ALOX15 (0.50) RPS6KA3CNR2CNR1AKR1C2CA12
SCHEMBL17037056 0.81 ACHE (0.45) RPS6KA3CNR2CNR1AKR1C3AKR1C2
SCHEMBL4527011 0.81 RPS6KA3 (0.45) RPS6KA3AKR1C3AKR1C2ACHEPDK2
SCHEMBL30522729 0.81 CA12 (0.51) RPS6KA3CNR2CNR1CA12CA9
SCHEMBL20721787 0.79 CNR2 (0.51) RPS6KA3CNR2CNR1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177518-A1 Organic compounds Novartis AG (CH) 2010-04-21 EP disclosed
EP-1833816-B1 SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-11-11 EP disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 WO disclosed